Literature DB >> 25682778

Implementation of client versus care-provider strategies to improve external cephalic version rates: a cluster randomized controlled trial.

Floortje Vlemmix1, Ageeth N Rosman, Marlies E Rijnders, Antje Beuckens, Brent C Opmeer, Ben W J Mol, Marjolein Kok, Margot A H Fleuren.   

Abstract

OBJECTIVE: To determine the effectiveness of a client or care-provider strategy to improve the implementation of external cephalic version.
DESIGN: Cluster randomized controlled trial.
SETTING: Twenty-five clusters; hospitals and their referring midwifery practices randomly selected in the Netherlands. POPULATION: Singleton breech presentation from 32 weeks of gestation onwards.
METHODS: We randomized clusters to a client strategy (written information leaflets and decision aid), a care-provider strategy (1-day counseling course focused on knowledge and counseling skills), a combined client and care-provider strategy and care-as-usual strategy. We performed an intention-to-treat analysis. MAIN OUTCOME MEASURES: Rate of external cephalic version in various strategies. Secondary outcomes were the percentage of women counseled and opting for a version attempt.
RESULTS: The overall implementation rate of external cephalic version was 72% (1169 of 1613 eligible clients) with a range between clusters of 8-95%. Neither the client strategy (OR 0.8, 95% CI 0.4-1.5) nor the care-provider strategy (OR 1.2, 95% CI 0.6-2.3) showed significant improvements. Results were comparable when we limited the analysis to those women who were actually offered intervention (OR 0.6, 95% CI 0.3-1.4 and OR 2.0, 95% CI 0.7-4.5).
CONCLUSIONS: Neither a client nor a care-provider strategy improved the external cephalic version implementation rate for breech presentation, neither with regard to the number of version attempts offered nor the number of women accepting the procedure.
© 2015 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Breech delivery; breech presentation; external cephalic version; implementation; mode of delivery

Mesh:

Year:  2015        PMID: 25682778     DOI: 10.1111/aogs.12609

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Atosiban versus fenoterol as a uterine relaxant for external cephalic version: randomised controlled trial.

Authors:  Joost Velzel; Floortje Vlemmix; Brent C Opmeer; Jan F M Molkenboer; Corine J Verhoeven; Mariëlle G van Pampus; Dimitri N M Papatsonis; Joke M J Bais; Karlijn C Vollebregt; Liesbeth van der Esch; Joris A M Van der Post; Ben Willem Mol; Marjolein Kok
Journal:  BMJ       Date:  2017-01-26

2.  Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study.

Authors:  Y M Slootweg; C Zwiers; J M Koelewijn; E van der Schoot; D Oepkes; I L van Kamp; M de Haas
Journal:  BJOG       Date:  2022-03-18       Impact factor: 7.331

3.  Evaluation of a blended care programme for caregivers and working pregnant women to prevent adverse pregnancy outcomes: an intervention study.

Authors:  Monique van Beukering; Adeline Velu; Lydia Henrike Nicole Schonewille; Ruben Duijnhoven; Ben Willem Mol; Teus Brand; Monique Frings-Dresen; Marjolein Kok
Journal:  Occup Environ Med       Date:  2021-04-19       Impact factor: 4.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.